RTI Surgical, Inc. (NASDAQ:RTIX) posted its quarterly earnings results on Thursday. The medical equipment provider reported $0.01 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.01, Bloomberg Earnings reports. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The firm had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. The company’s quarterly revenue was up .2% compared to the same quarter last year. RTI Surgical updated its FY17 guidance to $0.05-0.07 EPS.
COPYRIGHT VIOLATION NOTICE: “RTI Surgical, Inc. (RTIX) Releases Quarterly Earnings Results, Hits Expectations” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/03/rti-surgical-inc-rtix-releases-quarterly-earnings-results-hits-expectations.html.
Several analysts have recently weighed in on RTIX shares. BidaskClub downgraded shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Zacks Investment Research downgraded shares of RTI Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th.
In related news, Director Nicholas J. Valeriani acquired 5,500 shares of the stock in a transaction that occurred on Monday, August 21st. The stock was purchased at an average price of $4.70 per share, with a total value of $25,850.00. Following the transaction, the director now owns 47,754 shares of the company’s stock, valued at approximately $224,443.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John N. Varela bought 12,000 shares of RTI Surgical stock in a transaction on Friday, August 11th. The shares were acquired at an average price of $4.85 per share, for a total transaction of $58,200.00. Following the completion of the acquisition, the executive vice president now owns 47,998 shares in the company, valued at $232,790.30. The disclosure for this purchase can be found here. Company insiders own 4.90% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
What are top analysts saying about RTI Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RTI Surgical Inc. and related companies.